Conclusion of drug discount agreements according to § 130a paragraph 8 of the German Civil Code V
A02BC05 - EsomeprazolLot 1001 - esomeprazole; 3 surcharges
L01AX03 - TemozolomideLot 1011 - temozolomide; 3 surcharges
L02BG03 - AnastrozoleLot 1013 - Anastrazole; 1 surcharge
L02BG04 - LetrozoleLot 1014 - Letrozole; 3 surcharges
L02BG06 - ExemestanLot 1015 - Exemestane; 1 surcharge
L04AA13 - LeflunomidLot 1016 - leflunomide; 3 surcharges
M05BA07 - RisedronsäureLot 1017 - Risedronic acid; 3 surcharges
N02AA03 - HydromorphoneLot 1018 - Hydromorphone; 3 surcharges
N02BF02 - PregabalinLot 1019 - Pregabalin; 3 surcharges
N02CC04 - RizatriptanLot 1020 - rizatriptan; 3 surcharges
N03AD01 - EthosuximidLot 1021 - ethosuximide; 1 surcharge
A10BX02 - RepaglinidCompartment lot 1002 - repaglinide; 1 surcharge
N04BD02 - RasagilinLot 1022 - rasagiline; 3 surcharges
C01EB18 - RanolazinLot 1003 - Ranolazine; 1 surcharge
C09CA01 - LosartanFachlot 1004 - Losartan; 3 surcharges
C09DA01 - Losartan and diureticsLot 1005 - losartan potassium and hydrochlorothiazide; 1 surcharge
D01AE14 - CiclopiroxLot 1006 - Ciclopirox olamine; 1 surcharge
D06BB10 - ImiquimodLot 1007 - imiquimod; 1 surcharge
G01AF02 - ClotrimazoleLot 1008 - clotrimazole; 1 surcharge
G04BD06 - PropiverinLot 1009 - propiverine; 1 surcharge